Medicare Enrolled

Dr. David Kuter, MD DPHIL

Internal Medicine · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
55 FRUIT ST, Boston, MA 02114
6177246193
In practice since 2005 (20 years)
NPI: 1457342024 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kuter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kuter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kuter

Dr. David Kuter is an internal medicine specialist in Boston, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kuter performed 301 Medicare services across 203 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kuter received a total of $609,142 from 35 pharmaceutical and/or device companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kuter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 301 Medicare services $609,142 industry payments

Medicare Practice Summary

Medicare Utilization ↗
301
Medicare services
Bottom 36% in MA for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
203
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
192 $105 $614
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
39 $24 $126
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
29 $142 $805
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
24 $99 $416
Prolonged inpatient or observation care, each additional 15 minutes
This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider.
17 $26 $163
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$609,142
Total received (2018-2024)
Avg $87,020/year across 7 years
Top 0% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
290
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$407,142 (66.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$112,038 (18.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$89,962 (14.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$81,779
2023
$93,694
2022
$90,297
2021
$53,031
2020
$67,645
2019
$80,502
2018
$142,194

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$45,080
Alexion Pharmaceuticals, Inc.
$19,800
SANOFI US SERVICES INC.
$4,512
SOBI, INC
$4,269
Novartis Pharmaceuticals Corporation
$4,224
Merck Sharp & Dohme LLC
$2,360
E.R. Squibb & Sons, L.L.C.
$1,500
Takeda Pharmaceuticals U.S.A., Inc.
$34
Top 3 companies account for 84.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$165,394
GENZYME CORPORATION
$104,185
UCB SA
$45,815
Novartis Pharmaceuticals Corporation
$34,903
Swedish Orphan Biovitrum AB
$31,124
NOVARTIS PHARMACEUTICALS CORPORATION
$29,709
Alexion Pharmaceuticals, Inc.
$28,403
Dova Pharmaceuticals
$26,547
SWEDISH ORPHAN BIOVITRUM AB
$23,464
SANOFI US SERVICES INC.
$13,330
Rigel Pharmaceuticals, Inc.
$12,397
Shire North American Group Inc
$11,956
BioCryst Pharmaceuticals, Inc.
$8,215
PFIZER INC.
$8,178
Chugai Pharmaceutical Co., Ltd.
$7,670
Merck Sharp & Dohme LLC
$6,987
Novartis Pharma AG
$5,502
Merck Sharp & Dohme Corporation
$5,150
Sobi, Inc
$4,923
UCB, Inc.
$4,830
Apellis Pharmaceuticals, Inc.
$4,607
Daiichi Sankyo Inc.
$4,525
SOBI, INC
$4,269
Shionogi Inc
$3,988
BIOVERATIV THERAPEUTICS INC.
$3,165
Incyte Corporation
$2,460
Alnylam Pharmaceuticals Inc.
$2,222
E.R. Squibb & Sons, L.L.C.
$1,629
New York Blood Center, Inc.
$1,200
Regeneron Pharmaceuticals, Inc.
$881
Takeda Pharmaceuticals U.S.A., Inc.
$784
Ipsen Bioscience Inc
$580
ARGENX US, INC.
$108
Agios Pharmaceuticals, Inc.
$21
UCB Biosciences Inc.
$19
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
AIHA · CABLIVI · CERDELGA · DOPTELET · Doptelet · ELELYSO · ENJAYMO · Empaveli · Fabhalta · GIVLAARI · INJECTAFER · Mulpleta · NO PRODUCT DISCUSSED · Neulasta · Nplate · Orladeyo · PRM_PROMACTA_ONCOLOGY · PROMACTA · PYRUKYND · SOLIRIS · Savaysa · Soliris · Tavalisse · ULTOMIRIS · Ultomiris · VPRIV · VYVGART
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for internal medicine in MA.

Looking for an internal medicine specialist in Boston?
Compare internal medicine physicians in the Boston area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
5,615
Per 100K population
717.9
County median income
$92,859
Nearest hospital
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kuter is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 0% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kuter experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Kuter performed 192 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kuter receive payments from pharmaceutical companies?
Yes. Dr. Kuter received a total of $609,142 from 35 companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kuter's costs compare to other internal medicine physicians in Boston?
Dr. Kuter's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kuter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →